Named on 8 rounds in the feed, most often at Series B and in AI.
Rounds from 2020-07-23 to 2025-03-04
ROUNDS
8
joined, none as lead
ROUNDS JOINED · USD
$696.1M
across 8 rounds
CO-INVESTORS
32
named beside it
Named on 8 rounds in the feed, most often at Series B and in AI.
Rounds from 2020-07-23 to 2025-03-04
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Quantexa Quantexa provides a Decision Intelligence platform that connects fragmented data to improve decision-making for industries like banking, insurance, and public sector. | Series F Verified against 1 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2025-03-04 | [ PART ] |
OMass Therapeutics A UK based biotechnology company developing small molecule therapeutics against highly validated targets | Series B ext. Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $12.5M | 2023-05-15 | [ PART ] |
Quantexa Quantexa provides a Decision Intelligence platform that connects fragmented data to improve decision-making for industries like banking, insurance, and public sector. | Series E Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $129M | 2023-04-04 | [ PART ] |
Quantum Motion Quantum Motion develops utility-scale quantum computers using silicon technology, targeting clients in fields like chemistry, medicine, and artificial intelligence. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50.9M | 2023-02-21 | [ PART ] |
CloudNC A technology company that created the leading AI software for precision machining | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $45M | 2022-06-21 | [ PART ] |
Microbiotica A clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $65.9M | 2022-03-07 | [ PART ] |
Quantexa Quantexa provides a Decision Intelligence platform that connects fragmented data to improve decision-making for industries like banking, insurance, and public sector. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $153M | 2021-07-13 | [ PART ] |
Quantexa Quantexa provides a Decision Intelligence platform that connects fragmented data to improve decision-making for industries like banking, insurance, and public sector. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $64.7M | 2020-07-23 | [ PART ] |